Cite
MLA Citation
G. Ricco et al.. “In HCV infected patients with cirrhosis Squamous Cell Carcinoma Antigen (SCCA)-IgM levels may contribute to identify the individual risk of HCC development after antiviral therapy.” Digestive and liver disease, vol. 49, no. 1, n.d., pp. e48–e49. http://access.bl.uk/ark:/81055/vdc_100045027143.0x00000a